Pacific Biosciences of California Community

NasdaqGS:PACB Community

1 Narratives written by author
0 Comments on narratives written by author
39 Fair Values set on narratives written by author

Pacific Biosciences of California

AN

AnalystConsensusTarget

Consensus Narrative from 10 Analysts

Vega Shipments, SMRT Cells And Revio Chemistry Will Boost Efficiency

Key Takeaways Advancements in technology and cost efficiencies are poised to drive revenue growth and improve margins as the platform scales and becomes more widely adopted. Strategic focus on clinical applications and operating efficiency indicates potential for sustainable revenue growth and improved financial health.

US$2.30

FV

42.5% undervalued

18.01%

Revenue growth p.a.

0

0

24

6 days ago